(FINANCIAL TIMES) - With more than one billion Covid-19 vaccine doses administered to adults around the world, debate is turning to the contentious question of whether or when to extend vaccinations to children.
The biggest vaccine manufacturers have all trialled their jabs on young people, including babies in some cases. Canada this week became the first country to approve a vaccine for children as it authorised the Pfizer-BioNTech shot, which the company said was 100 per cent effective in adolescents aged between 12 and 15.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you